{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T12:16:00Z","timestamp":1674130560553},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Natural Science Fund Committee of China","award":["81100339"],"award-info":[{"award-number":["81100339"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.leukres.2015.09.012","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T21:46:23Z","timestamp":1442871983000},"page":"1347-1352","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of immune manifestations between refractory cytopenia of childhood and aplastic anemia in children: A single-center retrospective study"],"prefix":"10.1016","volume":"39","author":[{"given":"Jun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2015.09.012_bib0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.2011.08724.x","article-title":"Advances in the prognostication and management of advanced MDS in children","volume":"154","author":"Hasle","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0010","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3109\/10428194.2011.584002","article-title":"Myelodysplastic syndromes: the role of the immune system in pathogenesis","volume":"52","author":"Warlick","year":"2011","journal-title":"Leuk. Lymphoma."},{"key":"10.1016\/j.leukres.2015.09.012_bib0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1200\/JCO.2010.31.2686","article-title":"Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care\u2014SAKK 33\/99","volume":"29","author":"Passweg","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0020","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1200\/JCO.2007.11.9214","article-title":"Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy","volume":"26","author":"Sloand","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2141.2009.07921.x","article-title":"Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes","volume":"148","author":"Alfinito","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/pbc.21075","article-title":"Myelodysplastic syndrome with trisomy 8 associated with Beh\u00e7et syndrome: an immunologic link to a karyotypic abnormality","volume":"50","author":"Thachil","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.leukres.2015.09.012_bib0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s10067-004-1059-4","article-title":"Myelodysplastic syndrome associated with multiple autoimmune disorders","volume":"24","author":"Farmakis","year":"2005","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/rheumatology\/keh136","article-title":"Autoimmune phenomena in myelodysplastic syndrome: a 4-yr prospective study","volume":"43","author":"Giannouli","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.leukres.2015.09.012_bib0045","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/acr.20504","article-title":"Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study","volume":"63","author":"de Hollanda","year":"2011","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.leukres.2015.09.012_bib0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1385\/MO:23:3:385","article-title":"Immunologic abnormalities in myelodysplastic syndromes: clinical features and characteristics of the lymphoid population","volume":"23","author":"Marisavljevi\u0107","year":"2006","journal-title":"Med. Oncol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.leu.2404590","article-title":"Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome","volume":"21","author":"Epling-Burnette","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2015.09.012_bib0060","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/leu.2008.333","article-title":"Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS)","volume":"23","author":"Kotsianidis","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2015.09.012_bib0065","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/leu.2010.149","article-title":"Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome","volume":"24","author":"Carlsten","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2015.09.012_bib0070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-0609.2005.00551.x","article-title":"Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis","volume":"75","author":"Stifter","year":"2005","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/jaut.2000.0459","article-title":"Altered self-reactive antibody repertoires are a general feature of patients with myelodysplastic syndrome","volume":"16","author":"Stahl","year":"2001","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.leukres.2015.09.012_bib0080","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1038\/bcj.2014.28","article-title":"T-cell receptor V\u03b2 skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS","volume":"4","author":"Aalbers","year":"2014","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2015.09.012_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPH.0000000000000046","article-title":"Pediatric myelodysplastic syndromes: they do exist!","volume":"36","author":"Glaubach","year":"2014","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MOH.0b013e3282fa7470","article-title":"Aplastic anemia","volume":"15","author":"Young","year":"2008","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0095","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00277-008-0671-9","article-title":"Aplastic anemia and concomitant autoimmune diseases","volume":"88","author":"Stalder","year":"2009","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0100","first-page":"5","article-title":"Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones","volume":"45","author":"Maciejewski","year":"2007","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0105","series-title":"International Agency for Research on Cancer. WHO classification of haematopoietic and lymphoid tissue","first-page":"104","article-title":"Childhood myelodysplastic syndromes","author":"Baumann","year":"2008"},{"key":"10.1016\/j.leukres.2015.09.012_bib0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","article-title":"Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality","volume":"48","author":"Camitta","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.09.012_bib0115","series-title":"Practical Pediatrics","author":"Hu","year":"2000"},{"key":"10.1016\/j.leukres.2015.09.012_bib0120","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-2141.1996.426964.x","article-title":"Acute myeloid and T-cell acute lymphoblastic leukaemia with aberrant antigen expression exhibit similar TCRdelta gene rearrangements","volume":"92","author":"Schmidt","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0125","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2141.2011.08683.x","article-title":"Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy","volume":"153","author":"Aggarwal","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb05310.x","article-title":"Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy","volume":"91","author":"Enright","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1096-8652(200008)64:4<271::AID-AJH6>3.0.CO;2-C","article-title":"Type I and type II T-cell profiles in aplastic anemia and refractory anemia","volume":"64","author":"Tsuda","year":"2000","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.seminhematol.2007.11.006","article-title":"The role of the immune system in myelodysplasia: implications for therapy","volume":"45","author":"Sloand","year":"2008","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0925-5710(97)00042-X","article-title":"Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients","volume":"66","author":"Okamoto","year":"1997","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0150","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2169\/internalmedicine.49.3477","article-title":"Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA)","volume":"49","author":"Li","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.leukres.2015.09.012_bib0155","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y","article-title":"Human natural killer cells: their origin, receptors and function","volume":"32","author":"Moretta","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.leukres.2015.09.012_bib0160","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.leu.2404080","article-title":"Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes","volume":"20","author":"Kiladjian","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2015.09.012_bib0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1756-185X.2012.01704.x","article-title":"Low C3 levels is associated with neutropenia in a proportion of patients with myelodysplastic syndrome: retrospective analysis","volume":"15","author":"Kim","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.leukres.2015.09.012_bib0170","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/leu.2008.23","article-title":"T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia","volume":"22","author":"de Vries","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2015.09.012_bib0175","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood-2005-09-3902","article-title":"Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome","volume":"108","author":"Wlodarski","year":"2006","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615303830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615303830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T15:12:37Z","timestamp":1599577957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212615303830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0145212615303830"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2015.09.012","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of immune manifestations between refractory cytopenia of childhood and aplastic anemia in children: A single-center retrospective study","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2015.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}